(7.ALPHA.,17.ALPHA.)-17-HYDROXY-3-OXO-7-(OXOACETYL)PREGNA-4,9(11)-DIENE-21-CARBOXYLIC ACID .GAMMA.-LACTONE
UNII 8PJ9GK7FY9
Substance Identification & Data
This profile provides standardized clinical and technical data for (7.alpha.,17.alpha.)-17-hydroxy-3-oxo-7-(oxoacetyl)pregna-4,9(11)-diene-21-carboxylic Acid .gamma.-lactone, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8PJ9GK7FY9.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 610785-46-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C24H28O5 LPYRZIIENXABSC-IUFLCPJJSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (7.alpha.,17.alpha.)-17-hydroxy-3-oxo-7-(oxoacetyl)pregna-4,9(11)-diene-21-carboxylic Acid .gamma.-lactone. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.